Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Hernandez

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 24, 2024
Projected prescription drug expenditures in 2024: Looking ahead to the inflation reduction eraInmaculada Hernandez
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 13, 2015
Time to reconsider dabigatran 110 mg in the USAInmaculada Hernandez
JAMA Internal Medicine|August 8, 2017
Revisiting Outcomes-Based Pricing Propositions for the PCSK9 Inhibitor EvolocumabInmaculada Hernandez
Journal of Pharmaceutical Innovation|October 3, 2017
Comparing Adoption of Breakthrough and "Me-too" Drugs among Medicare Beneficiaries: A Case Study of Dipeptidyl Peptidase-4 InhibitorsInmaculada Hernandez, Yuting Zhang
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 10, 2017
Using predictive analytics and big data to optimize pharmaceutical outcomesInmaculada Hernandez, Yuting Zhang
JAMA Internal Medicine|July 7, 2015
Risk of Bleeding With Dabigatran in 2010-2011 Medicare DataInmaculada Hernandez, Yuting Zhang
Journal of Evaluation in Clinical Practice|June 11, 2015
Comparing clinical and economic outcomes of biologic and conventional medications in postmenopausal women with osteoporosisInmaculada Hernandez, Yuting Zhang
Gerontology & Geriatric Medicine|May 6, 2017
Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012Inmaculada Hernandez, Yuting Zhang
Journal of Managed Care & Specialty Pharmacy|December 28, 2023
A primer on brand-name prescription drug reimbursement in the United StatesInmaculada Hernandez, Anna Hung
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 18, 2016
Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D DataInmaculada Hernandez, Yuting Zhang
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 24, 2024
Projected prescription drug expenditures in 2024: Looking ahead to the inflation reduction eraInmaculada Hernandez
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 13, 2015
Time to reconsider dabigatran 110 mg in the USAInmaculada Hernandez
JAMA Internal Medicine|August 8, 2017
Revisiting Outcomes-Based Pricing Propositions for the PCSK9 Inhibitor EvolocumabInmaculada Hernandez
Journal of Pharmaceutical Innovation|October 3, 2017
Comparing Adoption of Breakthrough and "Me-too" Drugs among Medicare Beneficiaries: A Case Study of Dipeptidyl Peptidase-4 InhibitorsInmaculada Hernandez, Yuting Zhang
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 10, 2017
Using predictive analytics and big data to optimize pharmaceutical outcomesInmaculada Hernandez, Yuting Zhang
JAMA Internal Medicine|July 7, 2015
Risk of Bleeding With Dabigatran in 2010-2011 Medicare DataInmaculada Hernandez, Yuting Zhang
Journal of Evaluation in Clinical Practice|June 11, 2015
Comparing clinical and economic outcomes of biologic and conventional medications in postmenopausal women with osteoporosisInmaculada Hernandez, Yuting Zhang
Gerontology & Geriatric Medicine|May 6, 2017
Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012Inmaculada Hernandez, Yuting Zhang
Journal of Managed Care & Specialty Pharmacy|December 28, 2023
A primer on brand-name prescription drug reimbursement in the United StatesInmaculada Hernandez, Anna Hung
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 18, 2016
Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D DataInmaculada Hernandez, Yuting Zhang
Pageof 19